Treat-to-Target Outcomes and Measures of Treatment Success in Three Phase 3 Trials of Tapinarof Cream 1% Once Daily for Mild to Severe Plaque Psoriasis. J of Skin. 2022;6(6):s52. doi:10.25251/skin.6.supp.52